Please login to the form below

Not currently logged in
Email:
Password:

OSE Immunotherapeutics

This page shows the latest OSE Immunotherapeutics news and features for those working in and with pharma, biotech and healthcare.

Boehringer taps Korea’s Bridge for Ofev follow-up

Boehringer taps Korea’s Bridge for Ofev follow-up

Last year, Boehringer also acquired the oncolytic virus specialist ViraTherapeutics for 210m and licensed a checkpoint inhibitor from OSE Immunotherapeutics in a deal valued at up to 1bn.

Latest news

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Iris Pauporté joins OSE Immunotherapeutics Iris Pauporté joins OSE Immunotherapeutics

    She becomes clinical project director at the French biotech. Nantes, France-based biotech OSE Immunotherapeutics has bolstered its clinical team with the appointment of Iris Pauporté as clinical project director. ... Alain Chatelin, medical director at

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics